Børge Sørvoll
Finanzdirektor/CFO bei ARCTICZYMES TECHNOLOGIES ASA
Vermögen: 223 185 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Marit Sjo Lorentzen | M | 56 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | - |
Olav Lanes | M | 52 | 24 Jahre | |
Jethro Holter | M | 52 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | 9 Jahre |
Dino DiCamillo | M | 66 | 12 Jahre | |
Rolf Einar Engstad | M | 65 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | - |
Dirk Hahneiser | M | 56 | 2 Jahre | |
Bernd Striberny | M | - | - | |
Darren Ellis | M | - | 2 Jahre | |
Michael Akoh | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Svein Wilhelm Faye Lien | M | 70 | 7 Jahre | |
Martin Hunt | M | 66 | - | |
Volker Wedershoven | M | - | - | |
Kjersti Grimsrud | F | 63 | 4 Jahre | |
Marie Roskrow | M | - | - | |
Richard Stuart Godfrey | M | 58 | - | |
Arne Reinemo | M | - | - | |
Inger Rydin | F | 67 | 5 Jahre | |
Christian Jørgensen | M | 65 | 2 Jahre | |
Jane Theaker | F | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Norwegen | 19 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Børge Sørvoll
- Persönliches Netzwerk